PT-141

The melanocortin receptor agonist

Listed strength: 10 mg
Mol. weight: 1025 g/mol
Residues: —
Class: Melanocortin agonist (MC4R-preferring)

$50

10 mg lyophilized vial$5.00/mg · research use only

Reference specifications publishedResearch use only

Research use only · no human or veterinary use, consumption, administration, diagnosis, treatment, prevention, cosmetic use, or food use. Sold to qualified laboratory and analytical users.

Overview

PT-141 (bremelanotide) is a synthetic melanocortin receptor agonist structurally related to Melanotan II.

Mechanism (research literature)

PT-141 has a C-terminal carboxylic acid group, where Melanotan II has a C-terminal amide. The catalogue associates PT-141 with MC4R research.

Research context

PT-141 appears in melanocortin-receptor and neuroendocrine-signaling literature.

Specification

Listed format10 mg lyophilized vial

SequenceAc-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH

Molecular formulaC50H68N14O10

Molecular weight1025 g/mol

Catalogue referenceAGX-15

Listed price$50

TargetMC4R

Common questions

How does PT-141 differ structurally from Melanotan II?

PT-141 has a C-terminal carboxylic acid group in place of the amide group.

What is MC4R?

MC4R abbreviates melanocortin 4 receptor.

Learn how to read a catalogue record ↗

Lot documentation status ↗